Tykerb
/Tykerb (lapatinib) is a targeted therapy classified as a tyrosine kinase inhibitor, primarily used for the treatment of advanced or metastatic breast cancer in combination with other medications. It is administered as an oral tablet and is available by prescription only. Patients are advised that Tykerb may cause liver problems and should not be used in individuals with severe liver impairment.
FAQs about Tykerb
What should I do if I miss a dose?
If you miss a dose of Tykerb, take it as soon as you remember on the same day. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Tykerb while pregnant or breastfeeding?
Tykerb is not recommended for use during pregnancy due to potential harm to the fetus. It is also advised that women who are breastfeeding should not use Tykerb, as it may pass into breast milk and affect the nursing infant. This guidance is outlined in the Warnings and Precautions section of the label.
How should I store Tykerb?
Tykerb should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is specified in the Storage section of the label.
25
commonly-prescribed
medication.
